A Phase I study to explore the activity and safety of SCH532706, a small molecule chemokine receptor-5 antagonist in HIV type-1-infected patients

Pett, Sarah L., McCarthy, Michael C., Cooper, David A., MacRae, Karen, Tendolkar, Amol, Norris, Richard, Strizki, Julie M., Williams, Kenneth M. and Emery, Sean (2009) A Phase I study to explore the activity and safety of SCH532706, a small molecule chemokine receptor-5 antagonist in HIV type-1-infected patients. Antiviral Therapy, 14 1: 111-115.

Author Pett, Sarah L.
McCarthy, Michael C.
Cooper, David A.
MacRae, Karen
Tendolkar, Amol
Norris, Richard
Strizki, Julie M.
Williams, Kenneth M.
Emery, Sean
Title A Phase I study to explore the activity and safety of SCH532706, a small molecule chemokine receptor-5 antagonist in HIV type-1-infected patients
Journal name Antiviral Therapy   Check publisher's open access policy
ISSN 1359-6535
Publication date 2009-01-01
Sub-type Article (original research)
Volume 14
Issue 1
Start page 111
End page 115
Total pages 5
Publisher INT MEDICAL PRESS LTD
Language eng
Keyword Ccr5 Antagonist
Monotherapy
Vicriviroc
Efficacy
Q-Index Code C1
Q-Index Status Provisional Code
Institutional Status Unknown

Document type: Journal Article
Sub-type: Article (original research)
Collection: ResearcherID Downloads
 
Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 11 times in Thomson Reuters Web of Science Article | Citations
Google Scholar Search Google Scholar
Created: Sat, 18 Mar 2017, 01:00:47 EST by Web Cron